Quick Answer
Kiniksa Pharmaceuticals International, plc reported Earnings Per Share Diluted of $0.75 per share for the year ending 2025.
- Kiniksa Pharmaceuticals International, plc showed an increase of +225.0% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from Kiniksa Pharmaceuticals International, plc's annual report (Form 10-K), filed with the SEC on February 24, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 7 years of available data (2019 to 2025), Kiniksa Pharmaceuticals International, plc's Earnings Per Share Diluted has grown by 125.1%.
- Historical annual values: Fiscal year 2025: $0.75 per share | Fiscal year 2024: $0.60 (loss) per share | Fiscal year 2023: $0.20 per share | Fiscal year 2022: $2.60 per share | Fiscal year 2021: $2.30 (loss) per share | Fiscal year 2020: $2.61 (loss) per share | Fiscal year 2019: $2.99 (loss) per share.
- Data sourced from SEC EDGAR public filings as of June 21, 2026.
Last verified: